Membrane topology analysis of HIV-1 envelope glycoprotein gp41

Retrovirology

Volumn 7, Issue , 2010, Pages

  Liu, Shujun ^a   Kondo, Naoyuki ^a,b,c   Long, Yufei ^a   Xiao, Dan ^a   Iwamoto, Aikichi ^c   Matsuda, Zene ^a,b  

^a INSTITUTE OF BIOPHYSICS   (China)

^b THE UNIVERSITY OF TOKYO   (Japan)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 41;

AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CD4+ T LYMPHOCYTE; CELL MEMBRANE PERMEABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HYDROPHILICITY; MAMMAL CELL; MEMBRANE FUSION; MEMBRANE MODEL; MEMBRANE SPANNING DOMAIN; MEMBRANE STRUCTURE; NONHUMAN; PROKARYOTIC CELL; PROTEIN DOMAIN; VIRUS ENVELOPE; CELL LINE; CELL MEMBRANE; CHEMISTRY; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; PROTEIN TERTIARY STRUCTURE; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1; MAMMALIA; PROKARYOTA;

CELL LINE; CELL MEMBRANE; HIV ENVELOPE PROTEIN GP41; HIV INFECTIONS; HIV-1; HUMANS; MEMBRANE FUSION; PROTEIN STRUCTURE, TERTIARY;

EID: 78649490210     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-7-100     Document Type: Article

References (50)

1. Dettenhofer M, Yu XF. Characterization of the biosynthesis of human immunodeficiency virus type 1 Env from infected T-cells and the effects of glucose trimming of Env on virion infectivity. J Biol Chem 2001, 276:5985-5991. 10.1074/jbc.M008933200, 11054427.
2. Otteken A, Earl PL, Moss B. Folding, assembly, and intracellular trafficking of the human immunodeficiency virus type 1 envelope glycoprotein analyzed with monoclonal antibodies recognizing maturational intermediates. J Virol 1996, 70:3407-3415. 190213, 8648672.
3. Dash B, McIntosh A, Barrett W, Daniels R. Deletion of a single N-linked glycosylation site from the transmembrane envelope protein of human immunodeficiency virus type 1 stops cleavage and transport of gp160 preventing env-mediated fusion. J Gen Virol 1994, 75(Pt 6):1389-1397. 10.1099/0022-1317-75-6-1389, 8207403.
4. Fenouillet E, Jones IM. The glycosylation of human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) is important for the efficient intracellular transport of the envelope precursor gp160. J Gen Virol 1995, 76(Pt 6):1509-1514. 10.1099/0022-1317-76-6-1509, 7782780.
5. Eisenberg D, Wesson M. The most highly amphiphilic alpha-helices include two amino acid segments in human immunodeficiency virus glycoprotein 41. Biopolymers 1990, 29:171-177. 10.1002/bip.360290122, 2328285.
6. Kliger Y, Shai Y. A leucine zipper-like sequence from the cytoplasmic tail of the HIV-1 envelope glycoprotein binds and perturbs lipid bilayers. Biochemistry 1997, 36:5157-5169. 10.1021/bi962935r, 9136877.
7. Gawrisch K, Han KH, Yang JS, Bergelson LD, Ferretti JA. Interaction of peptide fragment 828-848 of the envelope glycoprotein of human immunodeficiency virus type I with lipid bilayers. Biochemistry 1993, 32:3112-3118. 10.1021/bi00063a024, 8457572.
8. Srinivas SK, Srinivas RV, Anantharamaiah GM, Segrest JP, Compans RW. Membrane interactions of synthetic peptides corresponding to amphipathic helical segments of the human immunodeficiency virus type-1 envelope glycoprotein. J Biol Chem 1992, 267:7121-7127.
9. Viard M, Ablan SD, Zhou M, Veenstra TD, Freed EO, Raviv Y, Blumenthal R. Photoinduced reactivity of the HIV-1 envelope glycoprotein with a membrane-embedded probe reveals insertion of portions of the HIV-1 Gp41 cytoplasmic tail into the viral membrane. Biochemistry 2008, 47:1977-1983. 10.1021/bi701920f, 2583176, 18198900.
10. Muesing MA, Smith DH, Cabradilla CD, Benton CV, Lasky LA, Capon DJ. Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus. Nature 1985, 313:450-458. 10.1038/313450a0, 2982104.
11. Haffar OK, Dowbenko DJ, Berman PW. Topogenic analysis of the human immunodeficiency virus type 1 envelope glycoprotein, gp160, in microsomal membranes. J Cell Biol 1988, 107:1677-1687. 10.1083/jcb.107.5.1677, 2115321, 3053734.
12. Yang C, Spies CP, Compans RW. The human and simian immunodeficiency virus envelope glycoprotein transmembrane subunits are palmitoylated. Proc Natl Acad Sci USA 1995, 92:9871-9875. 10.1073/pnas.92.21.9871, 40904, 7568235.
13. Rowell JF, Stanhope PE, Siliciano RF. Endocytosis of endogenously synthesized HIV-1 envelope protein. Mechanism and role in processing for association with class II MHC. J Immunol 1995, 155:473-488.
14. Kennedy RC, Henkel RD, Pauletti D, Allan JS, Lee TH, Essex M, Dreesman GR. Antiserum to a synthetic peptide recognizes the HTLV-III envelope glycoprotein. Science 1986, 231:1556-1559. 10.1126/science.3006246, 3006246.
15. Vella C, Ferguson M, Dunn G, Meloen R, Langedijk H, Evans D, Minor PD. Characterization and primary structure of a human immunodeficiency virus type 1 (HIV-1) neutralization domain as presented by a poliovirus type 1/HIV-1 chimera. J Gen Virol 1993, 74(Pt 12):2603-2607. 10.1099/0022-1317-74-12-2603, 7506299.
16. Cleveland SM, McLain L, Cheung L, Jones TD, Hollier M, Dimmock NJ. A region of the C-terminal tail of the gp41 envelope glycoprotein of human immunodeficiency virus type 1 contains a neutralizing epitope: evidence for its exposure on the surface of the virion. J Gen Virol 2003, 84:591-602. 10.1099/vir.0.18630-0, 12604810.
17. Lu L, Zhu Y, Huang J, Chen X, Yang H, Jiang S, Chen YH. Surface exposure of the HIV-1 env cytoplasmic tail LLP2 domain during the membrane fusion process: interaction with gp41 fusion core. J Biol Chem 2008, 283:16723-16731. 10.1074/jbc.M801083200, 2423246, 18408000.
18. Yue L, Shang L, Hunter E. Truncation of the membrane-spanning domain of human immunodeficiency virus type 1 envelope glycoprotein defines elements required for fusion, incorporation, and infectivity. J Virol 2009, 83:11588-11598. 10.1128/JVI.00914-09, 2772686, 19726514.
19. Shang L, Yue L, Hunter E. Role of the membrane-spanning domain of human immunodeficiency virus type 1 envelope glycoprotein in cell-cell fusion and virus infection. J Virol 2008, 82:5417-5428. 10.1128/JVI.02666-07, 2395181, 18353944.
20. Salzwedel K, Johnston PB, Roberts SJ, Dubay JW, Hunter E. Expression and characterization of glycophospholipid-anchored human immunodeficiency virus type 1 envelope glycoproteins. J Virol 1993, 67:5279-5288. 237926, 8102410.
21. Weiss CD, White JM. Characterization of stable Chinese hamster ovary cells expressing wild-type, secreted, and glycosylphosphatidylinositol-anchored human immunodeficiency virus type 1 envelope glycoprotein. J Virol 1993, 67:7060-7066. 238167, 8230430.
22. Owens RJ, Burke C, Rose JK. Mutations in the membrane-spanning domain of the human immunodeficiency virus envelope glycoprotein that affect fusion activity. J Virol 1994, 68:570-574. 236324, 8254774.
23. Miyauchi K, Komano J, Yokomaku Y, Sugiura W, Yamamoto N, Matsuda Z. Role of the specific amino acid sequence of the membrane-spanning domain of human immunodeficiency virus type 1 in membrane fusion. J Virol 2005, 79:4720-4729. 10.1128/JVI.79.8.4720-4729.2005, 1069530, 15795258.
24. Miyauchi K, Curran R, Matthews E, Komano J, Hoshino T, Engelman DM, Matsuda Z. Mutations of conserved glycine residues within the membrane-spanning domain of human immunodeficiency virus type 1 gp41 can inhibit membrane fusion and incorporation of Env onto virions. Jpn J Infect Dis 2006, 59:77-84.
25. Wang J, Kondo N, Long Y, Iwamoto A, Matsuda Z. Monitoring of HIV-1 envelope-mediated membrane fusion using modified split green fluorescent proteins. J Virol Methods 2009, 161:216-222. 10.1016/j.jviromet.2009.06.017, 19559731.
26. Kondo N, Ebihara A, Ru H, Kuramitsu S, Iwamoto A, Rao Z, Matsuda Z. Thermus thermophilus-derived protein tags that aid in preparation of insoluble viral proteins. Anal Biochem 2009, 385:278-285. 10.1016/j.ab.2008.10.050, 19084492.
27. Wilk T, Pfeiffer T, Bukovsky A, Moldenhauer G, Bosch V. Glycoprotein incorporation and HIV-1 infectivity despite exchange of the gp160 membrane-spanning domain. Virology 1996, 218:269-274. 10.1006/viro.1996.0190, 8615034.
28. Caras IW, Weddell GN, Williams SR. Analysis of the signal for attachment of a glycophospholipid membrane anchor. J Cell Biol 1989, 108:1387-1396. 10.1083/jcb.108.4.1387, 2115511, 2466848.
29. Cosson P, Lankford SP, Bonifacino JS, Klausner RD. Membrane protein association by potential intramembrane charge pairs. Nature 1991, 351:414-416. 10.1038/351414a0, 1827877.
30. van Genderen H, Kenis H, Lux P, Ungeth L, Maassen C, Deckers N, Narula J, Hofstra L, Reutelingsperger C. In vitro measurement of cell death with the annexin A5 affinity assay. Nat Protoc 2006, 1:363-367. 10.1038/nprot.2006.55, 17406257.
31. Drew D, Sjostrand D, Nilsson J, Urbig T, Chin CN, de Gier JW, von Heijne G. Rapid topology mapping of Escherichia coli inner-membrane proteins by prediction and PhoA/GFP fusion analysis. Proc Natl Acad Sci USA 2002, 99:2690-2695. 10.1073/pnas.052018199, 122409, 11867724.
32. Duffy EB, Barquera B. Membrane topology mapping of the Na+-pumping NADH: quinone oxidoreductase from Vibrio cholerae by PhoA-green fluorescent protein fusion analysis. J Bacteriol 2006, 188:8343-8351. 10.1128/JB.01383-06, 1698230, 17041063.
33. Los GV, Encell LP, McDougall MG, Hartzell DD, Karassina N, Zimprich C, Wood MG, Learish R, Ohana RF, Urh M, et al. HaloTag: a novel protein labeling technology for cell imaging and protein analysis. ACS Chem Biol 2008, 3:373-382. 10.1021/cb800025k, 18533659.
34. Kondo N, Miyauchi K, Meng F, Iwamoto A, Matsuda Z. Conformational changes of the HIV-1 envelope protein during membrane fusion are inhibited by the replacement of its membrane-spanning domain. J Biol Chem 2010, 285:14681-14688. 10.1074/jbc.M109.067090, 20197275.
35. Cloyd MW, Lynn WS. Perturbation of host-cell membrane is a primary mechanism of HIV cytopathology. Virology 1991, 181:500-511. 10.1016/0042-6822(91)90882-C, 1901681.
36. Zhang H, Dornadula G, Alur P, Laughlin MA, Pomerantz RJ. Amphipathic domains in the C terminus of the transmembrane protein (gp41) permeabilize HIV-1 virions: a molecular mechanism underlying natural endogenous reverse transcription. Proc Natl Acad Sci USA 1996, 93:12519-12524. 10.1073/pnas.93.22.12519, 38024, 8901614.
37. Gatti PJ, Choi B, Haislip AM, Fermin CD, Garry RF. Inhibition of HIV type 1 production by hygromycin B. AIDS Res Hum Retroviruses 1998, 14:885-892. 10.1089/aid.1998.14.885, 9671217.
38. Voss TG, Fermin CD, Levy JA, Vigh S, Choi B, Garry RF. Alteration of intracellular potassium and sodium concentrations correlates with induction of cytopathic effects by human immunodeficiency virus. J Virol 1996, 70:5447-5454. 190502, 8764056.
39. Miller MA, Cloyd MW, Liebmann J, Rinaldo CR, Islam KR, Wang SZ, Mietzner TA, Montelaro RC. Alterations in cell membrane permeability by the lentivirus lytic peptide (LLP-1) of HIV-1 transmembrane protein. Virology 1993, 196:89-100. 10.1006/viro.1993.1457, 8356808.
40. Chernomordik L, Chanturiya AN, Suss-Toby E, Nora E, Zimmerberg J. An amphipathic peptide from the C-terminal region of the human immunodeficiency virus envelope glycoprotein causes pore formation in membranes. J Virol 1994, 68:7115-7123. 237150, 7933093.
41. Arroyo J, Boceta M, Gonzalez ME, Michel M, Carrasco L. Membrane permeabilization by different regions of the human immunodeficiency virus type 1 transmembrane glycoprotein gp41. J Virol 1995, 69:4095-4102. 189144, 7769667.
42. Comardelle AM, Norris CH, Plymale DR, Gatti PJ, Choi B, Fermin CD, Haislip AM, Tencza SB, Mietzner TA, Montelaro RC, Garry RF. A synthetic peptide corresponding to the carboxy terminus of human immunodeficiency virus type 1 transmembrane glycoprotein induces alterations in the ionic permeability of Xenopus laevis oocytes. AIDS Res Hum Retroviruses 1997, 13:1525-1532. 10.1089/aid.1997.13.1525, 9390752.
43. Suarez T, Gallaher WR, Agirre A, Goni FM, Nieva JL. Membrane interface-interacting sequences within the ectodomain of the human immunodeficiency virus type 1 envelope glycoprotein: putative role during viral fusion. J Virol 2000, 74:8038-8047. 10.1128/JVI.74.17.8038-8047.2000, 112336, 10933713.
44. Suarez T, Nir S, Goni FM, Saez-Cirion A, Nieva JL. The pre-transmembrane region of the human immunodeficiency virus type-1 glycoprotein: a novel fusogenic sequence. FEBS Lett 2000, 477:145-149. 10.1016/S0014-5793(00)01785-3, 10899326.
45. Brugger B, Glass B, Haberkant P, Leibrecht I, Wieland FT, Krausslich HG. The HIV lipidome: a raft with an unusual composition. Proc Natl Acad Sci USA 2006, 103:2641-2646. 10.1073/pnas.0511136103, 1413831, 16481622.
46. Saez-Cirion A, Arrondo JL, Gomara MJ, Lorizate M, Iloro I, Melikyan G, Nieva JL. Structural and functional roles of HIV-1 gp41 pretransmembrane sequence segmentation. Biophys J 2003, 85:3769-3780. 10.1016/S0006-3495(03)74792-4, 1303679, 14645067.
47. Saez-Cirion A, Nir S, Lorizate M, Agirre A, Cruz A, Perez-Gil J, Nieva JL. Sphingomyelin and cholesterol promote HIV-1 gp41 pretransmembrane sequence surface aggregation and membrane restructuring. J Biol Chem 2002, 277:21776-21785. 10.1074/jbc.M202255200, 11929877.
48. Apellaniz B, Nir S, Nieva JL. Distinct mechanisms of lipid bilayer perturbation induced by peptides derived from the membrane-proximal external region of HIV-1 gp41. Biochemistry 2009, 48:5320-5331. 10.1021/bi900504t, 19449801.
49. Huarte N, Lorizate M, Kunert R, Nieva JL. Lipid modulation of membrane-bound epitope recognition and blocking by HIV-1 neutralizing antibodies. FEBS Lett 2008, 582:3798-3804. 10.1016/j.febslet.2008.10.012, 18930052.
50. Dimitrov AS, Rawat SS, Jiang S, Blumenthal R. Role of the fusion peptide and membrane-proximal domain in HIV-1 envelope glycoprotein-mediated membrane fusion. Biochemistry 2003, 42:14150-14158. 10.1021/bi035154g, 14640682.